Tagged with

R&D Today’s Thai pharmaceutical market requires companies to adapt new leadership styles and carry new medicines in order to adjust to the needs of patients and clients. T. Man Pharma’s motto: “committed, innovative and developing quality pharmaceutical products to meet international standards” is what the director of sales and marketing, and…

Boehringer Ingelheim Sirilak Suteekul explains the organization’s success in Thailand over the last couple of years, Thailand’s untapped potential as a regional center in Southeast Asia and how innovation adds value to society. As managing director of the organization for nearly two years, what have been your major challenges and accomplishments since…

locals Tuğçe Koç describes the company’s initial aspirations in targeting the higher value-added therapeutic area of oncology and the type of market opportunities that are present domestically and internationally. With over 25 years of experience, Onko Koçsel has established a strong foothold in the Turkish pharmaceutical industry—first with the introduction of…

basic research The Thailand Center of Excellence for Life Sciences (TCELS) CEO shares his ambitions to make Thailand a place for innovative business practices, the organization’s role in promoting and supporting research and the unique role TCELS plays in creating a regulatory frameworks for the life sciences industry. What special experiences led…

Otsuka Thai Otsuka’s president explains the Otsuka Group’s commitment to Thailand, the tremendous potential they see in the market in light of the opening up of the ASEAN Economic Community and his personal ambitions to ensure the company remains on a successful path. What is the importance of the Otsuka Group’s…

legal A founding partner of YükselKarkınKüçük, Gökhan Gökçe discusses the firm’s involvement with several high profile cases concerning the healthcare and life science sector’s reference pricing system, and also elaborates on the strategic trends in different types of operating structures as a result of shifting dynamics faced by the broader Turkish…

DHL The managing director of DHL Express Turkey, Markus Reckling highlights the strategic importance of Turkey to the global DHL Express portfolio and elaborates on the market opportunities present for DHL’s sector-focused solution, DHL Medical Express, within the broader context of Turkey’s healthcare and life sciences landscape. He also describes the…

locals The co-founder of Ekin Kimya discusses the need for greater regulation and monitoring of raw materials used in Turkish pharmaceutical manufacturing, his company’s key role as an educator and advisor to the industry with regards to international regulatory standards, and unique role as a supplier that provides robust support services,…

Mexico This graph shows the growth of the Mexican market between 2009 to 2013, in both units and volume, and broken down by type. For more data on the Mexican market, please download our latest 2015 free report here

Korea With a market value of USD 18.6 billion in 2013, Korea is ranked by IMS Health as the 14th largest pharma market in the world. Predicted to reach USD 24.3 billion by 2020, there is clearly a lot of room for Korea to grow. The following table outlines some of…

diagnostics In 2014, Hari Sabnani moved from Cardinal Health’s Puerto Rican affiliate to take the helm of Quest Diagnostics Puerto Rico, the country’s largest clinical lab. He discusses the change in position and emphasizes the importance of ensuring that equipment is being used to its fullest potential in a time of…

logistics José F. Oramas, country manager of UPS Puerto Rico, discusses the value-added services the packaging and logistics giant offers to meet the customer’s needs and the natural gateway that Puerto Rico offers between North and South America. What initial priorities did you set for yourself when you became general manager?…